Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

April 13, 2023

Conditions
Chronic Spontaneous Urticaria
Interventions
BIOLOGICAL

Tezepelumab Dose 1

Subcutaneous injection.

BIOLOGICAL

Tezepelumab Dose 2

Subcutaneous injection.

BIOLOGICAL

Omalizumab

Subcutaneous injection.

BIOLOGICAL

Placebo

Subcutaneous injection.

Trial Locations (81)

10029

Icahn School of Medicine at Mount Sinai, New York

10126

Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino

11527

Laiko General Hospital of Athens, Athens

Sotiria General Hospital, Athens

12203

*Charité*, Berlin

12462

Attikon University General Hospital of Athens, Athens

13620

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

16121

Andreas Syggros Hospital, Athens

16499

Ajou University Hospital, Suwon-si, Gyeonggi-do

18450

Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Gyeonggi-do

20089

IRCCS Istituto Clinico Humanitas, Rozzano MI

20122

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan

21224

Johns Hopkins Asthma and Allergy Center, Baltimore

29200

Centre Hospitalier Universitaire de Brest - Hôpital Morvan, Brest

30328

Advanced Medical Research PC, Sandy Springs

33016

The Community Research of South Florida, Miami Lakes

34295

Hôpital Saint Eloi, Montpellier

35209

Clinical Research Center of Alabama, Birmingham

37909

The Allergy Asthma and Sinus Center, East Tennessee Center for Clinical Research, Knoxville

38043

Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon, Grenoble

40215

Family Allergy and Asthma Research Institute, Louisville

40509

Bluegrass Allergy Care, Lexington

41124

Azienda Ospedaliero Universitaria di Modena, Modena

43016

Aventiv Research Inc, Dublin

45236

Bernstein Clinical Research Center LLC, Cincinnati

46014

Hospital General Universitario de Valencia, Valencia

46015

Hospital Arnau de Vilanova de Valencia, Valencia

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48103

David Fivenson MD Professional Liability Company, Ann Arbor

48202

Henry Ford Medical Center - New Center One, Detroit

48346

Clarkston Skin Research, Clarkston

55101

Johannes Gutenberg Universitaet Mainz, Mainz

56403

George Papageorgiou General Hospital of Thessaloniki, Thessaloniki

63110

Washington University School of Medicine, St Louis

66210

Epiphany Dermatology of Kansas, LLC, Overland Park

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

77056

Suzanne Bruce and Associates, Houston

78041

Cutis Wellness Dermatology and Dermatopathology, PLLC, Laredo

80907

Asthma and Allergy Associates PC, Colorado Springs

90025

Jonathan Corren MD Inc, Los Angeles

90045

Dermatology Research Associates, Los Angeles

90404

Clinical Science Institute, Santa Monica

92677

Avance Clinical Trials, Laguna Niguel

92708

First OC Dermatology, Fountain Valley

02919

Clinical Partners LLC, Johnston

T2J 7E1

Dermatology Research Institute Incorporated, Calgary

E3B 1G9

Brunswick Dermatology Centre, Fredericton

L8L 3C3

LEADER Research, Hamilton

L3P 1X3

Lynderm Research Inc, Markham

L5A 3V4

Cheema Research Incorporated, Mississauga

L3Y 5G8

Dr. S. K. Siddha Medicine Professional Corporation, Newmarket

L2H 1H5

Allergy Research Canada Incorporated, Niagara Falls

M3B 3S6

Gordon Sussman Clinical Research Incorporated, North York

G1V 4W2

Clinique Spécialisée en Allergie de la Capitale, Québec

06202

Centre Hospitalier Universitaire Archet 2, Nice

01307

Universitaetsklinikum Dresden, Dresden

00133

Fondazione Policlinico Tor Vergata, Roma

00168

Policlinico Universitario Agostino Gemelli, Roma

454-8509

Fujita Health University Bantane Hospital, Nagoya

734-8551

Hiroshima University Hospital, Hiroshima

080-0013

Takagi Dermatological Clinic, Obihiro-shi

211-0063

Kosugi Dermatology Clinic, Kawasaki-shi

221-0825

Nomura Dermatology Clinic, Yokohama

583-8588

Osaka Habikino Medical Center, Habikino-shi

593-8324

Dermatology and Ophthalmology Kume Clinic, Sakai-shi

173-8610

Nihon University Itabashi Hospital, Itabashi-ku

141-8625

NTT Medical Center Tokyo, Shinagawa-ku

80-214

Uniwersyteckie Centrum Kliniczne, Gdansk

91-495

AMICARE z ograniczona odpowiedzialnoscia spolka komandytowa, Lodz

92-213

SPZOZ Centralny Szpital Kliniczny, Lodz

20-081

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin

61-731

Clinical Research Center Spzoo Medic-R Spolka Komandytowa, Poznan

35-055

Kliniczny Szpital Wojewodzki nr 1 im Fryderyka Chopina, Rzeszów

02-473

Klinika Osipowicz and Turkowski Spzoo Opieka Wielospecjalistyczna Osipowicz and Turkowski, Warsaw

04-141

Wojskowy Instytut Medyczny, Warsaw

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

08003

Hospital del Mar, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT04833855 - Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria | Biotech Hunter | Biotech Hunter